Nanoplatin: Completed Phase I/II enrollment

NanoCarrier completed enrollment of 22 patients in the Phase II portion of an open-label, Singaporean and Taiwanese Phase I/II trial evaluating Nanoplatin in combination with gemcitabine. The Phase I ...